title: Two-year follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia.
authors.forename: David
authors.initials: D
authors.lastname: Esposito
authors.forename: Jérémie
authors.initials: J
authors.lastname: Aouillé
authors.forename: Frédéric
authors.initials: F
authors.lastname: Rouillon
authors.forename: Frédéric
authors.initials: F
authors.lastname: Limosin
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002940:Circadian Rhythm; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced*; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine